Aprea Therapeutics, Inc. (APRE)
NGS · Common · CUSIP 03836J102
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for APRE and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
03836J102
Market Cap
Mid Cap
IPO
10/3/2019 · $15.00/share
Business: Aprea Therapeutics, Inc.is a biopharmaceutical company headquartered in Boston, Massachusetts with research facilities in Stockholm, Sweden, focused on developing and commercializing novel cancer therapeutics that reactivate mutant tumor suppressor protein, p53.

Company Contact

CEO
Oren Gilad
CFO
John P. Hamill
Headquarters
3805 Old Easton Road, Doylestown, PA 18902
Phone
215-948-4119
Investor Relations
Mike Moyer · mmoyer@lifesciadvisors.com
General Email
info@aprea.com
Email Form
Contact Form »
SEC EDGAR Filings
View filings »